Babies are exposed to hormones in the womb

The length of a man’s fingers can provide clues to his risk of prostate cancer, according to new research.

A British Journal of Cancer study found men whose index finger was longer than their ring finger were significantly less likely to develop the disease.

Researchers made the discovery after comparing the hands of 1,500 prostate cancer patients with 3,000 healthy men.

The length of the fingers is fixed before birth and is thought to relate to sex hormone levels in the womb.

Being exposed to less testosterone before birth results in a longer index finger and may protect against prostate cancer later in life, say researchers at the University of Warwick and the Institute of Cancer Research.

One of the report authors, Professor Ros Eeles, said more studies would be needed, but if these confirmed the findings it could be used a simple test for prostate cancer risk.

She said: “This exciting finding means that finger pattern could potentially be used to select at-risk men for ongoing screening, perhaps in combination with other factors such as family history or genetic testing.”

The study was funded by the charities Prostate Action and Cancer Research UK.

Emma Halls, chief executive of Prostate Action, said: “This research brings us another step closer to helping determine risk factors for prostate cancer, which is possibly the biggest issue in current thinking about preventing and treating the disease.

“However, we are still a long way from reducing the number of men who die of prostate cancer every year and need more research and education in all areas to achieve this.”

Dr Helen Rippon, head of research at The prostate Cancer Charity, said the research added to growing evidence that the balance of hormones we are exposed to before birth influences our health for the rest of our lives.

But she said men with shorter index fingers should not be “unduly worried”.

“They share this trait with more than half of all men and it does not mean they will definitely develop prostate cancer in later life.”

.

.

Image and Article Source: BBC UK

The immune system is a combination of specialized blood cells called white blood cells and the chemicals they secrete called the antibodies. The body recognizes foreign cells or organisms, such as viruses and bacteria. It fights them using both white blood cells and antibodies. The white blood cells and antibodies find the foreign material and destroy it by breaking down. The immune system is very good from protecting us from microbes and viruses. Unfortunately, sometimes the immune system mistakes body cells for foreign material, causing the immune system to attack the body itself. This self-destruction causes inflammation and damages various body tissues. When the immune system mistakes the body cells for foreign material, an autoimmune disease results.

Lupus is a condition of chronic inflammation caused by an autoimmune disease. Patients with lupus produce abnormal antibodies in their blood that target tissues within their own body rather than foreign infectious agents. Because the antibodies and accompanying cells of inflammation can involve tissues anywhere in the body, lupus has the potential to affect a variety of areas of the body. Sometimes lupus can cause disease of the skin, heart, lungs, kidneys, joints, and/or nervous system. When only the skin is involved, the condition is called discoid lupus. When internal organs are involved, the condition is called systemic lupus erythematosus (SLE).

The precise reason for the abnormal autoimmunity that causes lupus is not known. Inherited genes, viruses, ultraviolet light, and drugs may all play some role. Genetic factors increase the tendency of developing autoimmune diseases, and autoimmune diseases such as lupus, rheumatoid arthritis, and immune thyroid disorders are more common among relatives of patients with lupus than the general population. Scientists believe that the immune system in lupus is more easily stimulated by external factors like viruses or ultraviolet light. Sometimes, symptoms of lupus can be precipitated or aggravated by only a brief period of sun exposure.

SLE is the most common form of the disease and can affect anyone at any time but is about eight to ten times more common or about 90% of those diagnosed with SLE are female and is most frequently seen in people who are in their early twenties to mid forties. There is an increased incidence of lupus in persons of African, Asian, Hispanic, and Native American descent.

Symptoms of lupus vary from patient to patient or from time to time for the same patient and this it difficult to diagnose lupus. Patients with SLE can develop different combinations of symptoms and organ involvement.They go through cycles of symptoms, called flares, and periods of wellness called remission. Common complaints and symptoms include fatigue, low-grade fever, loss of appetite, muscle aches, arthritis, ulcers of the mouth and nose, facial rash (“butterfly rash”), unusual sensitivity to sunlight (photosensitivity), inflammation of the lining that surrounds the lung (pleuritis) and the heart (pericarditis), and poor circulation to the fingers and toes with cold exposure (Reynaud’s phenomenon). More serious organ involvement with inflammation occurs in the brain, liver, and kidney. White blood cells and blood clotting factors also can be decreased in SLE, thereby increasing the risk of infection and bleeding. It is also known that some women with SLE can experience worsening of their symptoms prior to their menstrual periods. This phenomenon, together with the female predominance of SLE suggests that female hormones play an important role in the expression of SLE.

As lupus erythematosus is a chronic disease with no known cure, the goal of treatment is to relieve symptoms and protect organs by decreasing inflammation and/or the level of autoimmune activity in the body. Many patients with mild symptoms may need no treatment or only intermittent courses of antiinflammatory medications. Those with more serious illness involving damage to internal organ(s) may require high doses of corticosteroids in combination with other medications that suppress the body’s immune system. Patients with SLE need more rest during periods of active disease. During these periods, carefully prescribed exercise is still important to maintain muscle tone and range of motion in the joints